NDC 0338-0221

Plasma-Lyte A

Sodium Chloride, Sodium Gluconate, Sodium Acetate, Potassium Chloride And Magnesium Chloride

Plasma-Lyte A is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is Sodium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride; Magnesium Chloride.

Product ID0338-0221_3b95c0b2-4879-4af4-9319-a1a0ceb103f3
NDC0338-0221
Product TypeHuman Prescription Drug
Proprietary NamePlasma-Lyte A
Generic NameSodium Chloride, Sodium Gluconate, Sodium Acetate, Potassium Chloride And Magnesium Chloride
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date1979-02-02
Marketing CategoryNDA / NDA
Application NumberNDA017378
Labeler NameBaxter Healthcare Corporation
Substance NameSODIUM CHLORIDE; SODIUM GLUCONATE; SODIUM ACETATE; POTASSIUM CHLORIDE; MAGNESIUM CHLORIDE
Active Ingredient Strength526 mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL
Pharm ClassesOsmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [CS],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0338-0221-03

500 mL in 1 BAG (0338-0221-03)
Marketing Start Date1979-02-02
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0338-0221-03 [00338022103]

Plasma-Lyte A INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA017378
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1979-02-02

NDC 0338-0221-04 [00338022104]

Plasma-Lyte A INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA017378
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1979-02-02

Drug Details

Active Ingredients

IngredientStrength
SODIUM CHLORIDE526 mg/100mL

OpenFDA Data

SPL SET ID:6ec9e61c-2c26-402f-8604-f446b2e34058
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 801112
  • 801109
  • Pharmacological Class

    • Osmotic Laxative [EPC]
    • Increased Large Intestinal Motility [PE]
    • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
    • Osmotic Activity [MoA]
    • Potassium Compounds [CS]
    • Potassium Salt [EPC]
    • Osmotic Laxative [EPC]
    • Increased Large Intestinal Motility [PE]
    • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
    • Osmotic Activity [MoA]
    • Calculi Dissolution Agent [EPC]
    • Magnesium Ion Exchange Activity [MoA]
    • Osmotic Laxative [EPC]
    • Osmotic Activity [MoA]
    • Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]
    • Increased Large Intestinal Motility [PE]
    • Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
    • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]

    NDC Crossover Matching brand name "Plasma-Lyte A" or generic name "Sodium Chloride, Sodium Gluconate, Sodium Acetate, Potassium Chloride And Magnesium Chloride"

    NDCBrand NameGeneric Name
    0338-0221Plasma-Lyte ASodium Chloride, Sodium Gluconate, Sodium Acetate, Potassium Chloride and Magnesium Chloride
    65219-387Multiple Electrolytes pH 5.5sodium chloride, sodium gluconate, sodium acetate, potassium chloride and magnesium chloride
    65219-389Multiple Electrolytes pH 7.4sodium chloride, sodium gluconate, sodium acetate, potassium chloride and magnesium chloride

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.